These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27559425)

  • 21. A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson's disease at 3T: An efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet).
    Jo M; Oh SH
    Med Phys; 2020 Mar; 47(3):1151-1160. PubMed ID: 31883389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evaluation of the swallow tail sign in patients with parkinsonism and gait disorders.
    Kim DS; Tung GA; Akbar U; Friedman JH
    J Neurol Sci; 2021 Sep; 428():117581. PubMed ID: 34333378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility-Weighted 3T MRI of the Swallow Tail Sign in Multiple Sclerosis: A Case Control Study.
    Weber CE; Ebert A; Platten M; Gass A; Eisele P
    J Neuroimaging; 2020 Nov; 30(6):766-768. PubMed ID: 32857891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utility of visualisation of nigrosome-1 in patients with Parkinson's disease.
    Stezin A; Naduthota RM; Botta R; Varadharajan S; Lenka A; Saini J; Yadav R; Pal PK
    Eur Radiol; 2018 Feb; 28(2):718-726. PubMed ID: 28779393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparametric MR imaging of Parkinsonisms at 3 tesla: Its role in the differentiation of idiopathic Parkinson's disease versus atypical Parkinsonian disorders.
    Calloni SF; Conte G; Sbaraini S; Cilia R; Contarino VE; Avignone S; Sacilotto G; Pezzoli G; Triulzi FM; Scola E
    Eur J Radiol; 2018 Dec; 109():95-100. PubMed ID: 30527319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Swallow-Tail Sign and Correlations of Neuromelanin Signal with Susceptibility and Relaxations.
    Lee TW; Chen CY; Chen K; Tso CW; Lin HH; Lai YL; Hsu FT; Chung HW; Liu HS
    Tomography; 2021 Mar; 7(2):107-119. PubMed ID: 33801685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of 3D FLAIR and Dopamine Transporter Imaging in Patients With Parkinsonism.
    Oh SW; Shin NY; Lee JJ; Lee SK; Lee PH; Lim SM; Kim JW
    AJR Am J Roentgenol; 2016 Nov; 207(5):1089-1094. PubMed ID: 27489952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroimaging Assessment of Nigrosome 1 with a Multiecho Gre Magnetic Resonance Sequence in the Differentiation Between Parkinsons Disease from Essential Tremor and Healthy Individuals.
    Bienes GHAA; Zorzenon CPF; Alves ED; Tibana LAT; Borges V; Carrete H; Ferraz HB
    Tremor Other Hyperkinet Mov (N Y); 2021 May; 11():17. PubMed ID: 34046247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nigrosome 1 imaging: technical considerations and clinical applications.
    Kim EY; Sung YH; Lee J
    Br J Radiol; 2019 Sep; 92(1101):20180842. PubMed ID: 31067082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified Iron Deposition in Nigrosomes by Pharmacotherapy for the Management of Parkinson's Disease.
    Wang M; Wang H; Wang J; Lu S; Li C; Zhong X; Wang N; Ge R; Zheng Q; Chen J; Wang H
    Front Mol Biosci; 2022; 9():908298. PubMed ID: 35874610
    [No Abstract]   [Full Text] [Related]  

  • 31. Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3
    Schwarz ST; Xing Y; Naidu S; Birchall J; Skelly R; Perkins A; Evans J; Sare G; Martin-Bastida A; Bajaj N; Gowland P; Piccini P; Auer DP
    BMJ Open; 2017 Dec; 7(12):e016904. PubMed ID: 29247084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.
    Blazejewska AI; Schwarz ST; Pitiot A; Stephenson MC; Lowe J; Bajaj N; Bowtell RW; Auer DP; Gowland PA
    Neurology; 2013 Aug; 81(6):534-40. PubMed ID: 23843466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility-weighted imaging improves the diagnostic accuracy of 3T brain MRI in the work-up of parkinsonism.
    Meijer FJ; van Rumund A; Fasen BA; Titulaer I; Aerts M; Esselink R; Bloem BR; Verbeek MM; Goraj B
    AJNR Am J Neuroradiol; 2015 Mar; 36(3):454-60. PubMed ID: 25339647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiomic Features of the Nigrosome-1 Region of the Substantia Nigra: Using Quantitative Susceptibility Mapping to Assist the Diagnosis of Idiopathic Parkinson's Disease.
    Cheng Z; Zhang J; He N; Li Y; Wen Y; Xu H; Tang R; Jin Z; Haacke EM; Yan F; Qian D
    Front Aging Neurosci; 2019; 11():167. PubMed ID: 31379555
    [No Abstract]   [Full Text] [Related]  

  • 35. Simple quantitative planimetric measurement of nigrosome-1 for clinical settings.
    Chau MT; Agzarian M; Wilcox RA; Dwyer A; Bezak E; Todd G
    J Neurol Sci; 2023 Nov; 454():120857. PubMed ID: 37939625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson's Disease.
    Fu KA; Nathan R; Dinov ID; Li J; Toga AW
    Front Neurol; 2016; 7():174. PubMed ID: 27812347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using 'swallow-tail' sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson's disease: A susceptibility-weighted imaging study.
    Wang N; Yang H; Li C; Fan G; Luo X
    Eur Radiol; 2017 Aug; 27(8):3174-3180. PubMed ID: 28105503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and
    Jin L; Wang J; Wang C; Lian D; Zhou Y; Zhang Y; Lv M; Li Y; Huang Z; Cheng X; Fei G; Liu K; Zeng M; Zhong C
    Front Neurol; 2019; 10():100. PubMed ID: 30809189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Universality analysis of the existence of substantia nigra "swallow tail" appearance of non-Parkinson patients in 3T SWI.
    Gao P; Zhou PY; Wang PQ; Zhang GB; Liu JZ; Xu F; Yang F; Wu XX; Li G
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1307-14. PubMed ID: 27097951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nigrosome 1 visibility at susceptibility weighted 7T MRI-A dependable diagnostic marker for Parkinson's disease or merely an inconsistent, age-dependent imaging finding?
    Gramsch C; Reuter I; Kraff O; Quick HH; Tanislav C; Roessler F; Deuschl C; Forsting M; Schlamann M
    PLoS One; 2017; 12(10):e0185489. PubMed ID: 29016618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.